Anzeige
Mehr »
Donnerstag, 05.06.2025 - Börsentäglich über 12.000 News
Neuer Top-Geologe an Bord - zündet jetzt die nächste Kursrakete?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1JP9Y | ISIN: DK0060336014 | Ticker-Symbol: NZM2
Tradegate
04.06.25 | 17:33
63,20 Euro
+0,22 % +0,14
1-Jahres-Chart
NOVONESIS A/S Chart 1 Jahr
5-Tage-Chart
NOVONESIS A/S 5-Tage-Chart
RealtimeGeldBriefZeit
62,9863,1204.06.
62,9863,1404.06.

Aktuelle News zur NOVONESIS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoDSM-Firmenich schliesst Verkauf von Feed Enzymes Alliance an Novonesis ab9
NOVONESIS Aktie jetzt für 0€ handeln
Modsm-firmenich completes sale of its stake in Feed Enzymes Alliance to Novonesis for €1.5 billion314Press Release dsm-firmenich completes sale of its stake in Feed Enzymes Alliance to Novonesis for €1.5 billion Kaiseraugst (Switzerland), Maastricht (Netherlands), June 2, 2025 dsm-firmenich...
► Artikel lesen
MoNovonesis (Novozymes A/S): Novonesis completes acquisition of dsm-firmenichs's share of the Feed Enzyme Alliance3
MoNovonesis (Novozymes A/S): Transactions under Novonesis' share buyback program2
29.05.Morgan Stanley stuft Novonesis-Aktie mit Kursziel von 577,00 DKK als Overweight ein8
29.05.Morgan Stanley sets Novonesis stock Overweight with DKK577 target4
29.05.MS starts Novonesis at Overweight, says stock to rerate towards its prior highs2
28.05.UBS upgrades Novonesis to "buy," cuts Kerry to "neutral" on growth outlook3
27.05.UBS lifts Novonesis stock rating to Buy, target to DKK5304
27.05.UBS hebt Novonesis-Bewertung auf Kaufen an, Kursziel auf 530 DKK5
26.05.Novonesis (Novozymes A/S): Transactions under Novonesis' share buyback program2
19.05.Novonesis (Novozymes A/S): Combining EVP roles of Human Health Biosolutions and Strategy & Integration4
19.05.Novonesis (Novozymes A/S): Transactions under Novonesis' share buyback program5
12.05.Novonesis (Novozymes A/S): Transactions under Novonesis' share buyback program2
12.05.Novonesis (Novozymes A/S): Trading by management and close relations of management2
09.05.Novonesis A/S GAAP EPS of €0.40, revenue of €1.08B12
08.05.Novonesis (Novozymes A/S): Novonesis delivered a strong Q1 with 11% organic growth and confirms full-year outlook430COPENHAGEN, Denmark - May 8, 2025. The global leader in biosolutions, Novonesis, had a strong start to its financial year with organic sales growth of 11% and an adjusted EBITDA margin of 38.3%. The...
► Artikel lesen
08.05.Novonesis (Novozymes A/S): Interim report Q1 2025230Strong start to the year and confirmed full-year outlook Ester Baiget, President & CEO: "We delivered strong sales growth and earnings in the first quarter, with all four sales areas showing double-digit...
► Artikel lesen
05.05.Novonesis (Novozymes A/S): Transactions under Novonesis' share buyback program6
28.04.Novonesis (Novozymes A/S): Transactions under Novonesis' share buyback program5
Seite:  Weiter >>
52 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,2